|
ZNF382 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.11022302462516E-16 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
1.001040E-04 |
| Normal-vs-Stage3 |
3.539600E-03 |
| Normal-vs-Stage4 |
3.140200E-01 |
| Stage1-vs-Stage2 |
6.618800E-01 |
| Stage1-vs-Stage3 |
1.71220000400041E-08 |
| Stage1-vs-Stage4 |
2.44559927864429E-11 |
| Stage2-vs-Stage3 |
1.211800E-02 |
| Stage2-vs-Stage4 |
1.100090E-03 |
| Stage3-vs-Stage4 |
1.509220E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62503344114384E-12 |
| Normal-vs-AfricanAmerican |
7.75830000000477E-05 |
| Normal-vs-Asian |
5.611600E-02 |
| Caucasian-vs-AfricanAmerican |
8.881400E-01 |
| Caucasian-vs-Asian |
3.942000E-01 |
| AfricanAmerican-vs-Asian |
3.267200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.4894974142976E-11 |
| Normal-vs-Female |
8.11573031000989E-14 |
| Male-vs-Female |
1.851890E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.08070000000161E-05 |
| Normal-vs-Age(41-60Yrs) |
1.69586567011493E-12 |
| Normal-vs-Age(61-80Yrs) |
3.68889996327226E-09 |
| Normal-vs-Age(81-100Yrs) |
1.401700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.936000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.245000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.342800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.648300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.632000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.624800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.604660E-03 |
| Normal-vs-Grade 2 |
1.62458935193399E-12 |
| Normal-vs-Grade 3 |
6.80970002608916E-09 |
| Normal-vs-Grade 4 |
7.478600E-01 |
| Grade 1-vs-Grade 2 |
3.460400E-01 |
| Grade 1-vs-Grade 3 |
1.914030E-02 |
| Grade 1-vs-Grade 4 |
1.99221999999111E-05 |
| Grade 2-vs-Grade 3 |
1.303090E-03 |
| Grade 2-vs-Grade 4 |
2.46670017745032E-10 |
| Grade 3-vs-Grade 4 |
1.179790E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
<1E-12 |
| Normal-vs-ccB subtype |
6.13409999461467E-08 |
| ccA subtype-vs-ccB subtype |
4.215600E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.21910045894447E-10 |
| Normal-vs-N1 |
1.407820E-01 |
| N0-vs-N1 |
5.320200E-01 |
|
|
